Connection

SRIDEVI DEVARAJ to C-Reactive Protein

This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about C-Reactive Protein.
Connection Strength

8.605
  1. Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats. Diab Vasc Dis Res. 2012 Oct; 9(4):315-9.
    View in: PubMed
    Score: 0.330
  2. Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats. J Diabetes Complications. 2013 Jan-Feb; 27(1):23-8.
    View in: PubMed
    Score: 0.325
  3. C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin Chem. 2011 Dec; 57(12):1757-61.
    View in: PubMed
    Score: 0.313
  4. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol. 2011 Jun; 31(6):1397-402.
    View in: PubMed
    Score: 0.301
  5. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep. 2011 Feb; 13(1):31-42.
    View in: PubMed
    Score: 0.298
  6. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 2010 Mar; 12(2):110-8.
    View in: PubMed
    Score: 0.280
  7. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res. 2009 Dec 01; 84(3):479-84.
    View in: PubMed
    Score: 0.268
  8. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009 Jun; 20(3):182-9.
    View in: PubMed
    Score: 0.266
  9. Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem. 2009 Feb; 55(2):206-8.
    View in: PubMed
    Score: 0.258
  10. The evolving role of C-reactive protein in atherothrombosis. Clin Chem. 2009 Feb; 55(2):229-38.
    View in: PubMed
    Score: 0.258
  11. C-reactive protein induces M-CSF release and macrophage proliferation. J Leukoc Biol. 2009 Feb; 85(2):262-7.
    View in: PubMed
    Score: 0.256
  12. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis. 2009 Mar; 203(1):67-74.
    View in: PubMed
    Score: 0.249
  13. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol. 2008 May; 129(5):815-22.
    View in: PubMed
    Score: 0.247
  14. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008 Jul; 28(7):1368-74.
    View in: PubMed
    Score: 0.247
  15. The role of C-reactive protein activation of nuclear factor kappa-B in the pathogenesis of unstable angina. J Am Coll Cardiol. 2007 Jan 16; 49(2):195-7.
    View in: PubMed
    Score: 0.225
  16. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep. 2006 Nov; 8(6):477-86.
    View in: PubMed
    Score: 0.222
  17. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr. 2006 Oct; 84(4):756-61.
    View in: PubMed
    Score: 0.221
  18. Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia. Am J Cardiol. 2006 Sep 01; 98(5):641-3.
    View in: PubMed
    Score: 0.217
  19. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1170-6.
    View in: PubMed
    Score: 0.214
  20. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis. 2006 Jan; 184(1):48-52.
    View in: PubMed
    Score: 0.210
  21. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab. 2005 Aug; 90(8):4549-54.
    View in: PubMed
    Score: 0.201
  22. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1359-63.
    View in: PubMed
    Score: 0.200
  23. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol. 2004 Mar; 36(3):405-10.
    View in: PubMed
    Score: 0.185
  24. Validation of a multi-analyte immunoassay for distinguishing bacterial vs. viral infections in a pediatric cohort. Clin Chim Acta. 2023 Jun 01; 546:117387.
    View in: PubMed
    Score: 0.175
  25. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003 Jan 28; 107(3):398-404.
    View in: PubMed
    Score: 0.171
  26. Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol. 2003 Jan 15; 91(2):200-2.
    View in: PubMed
    Score: 0.171
  27. C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII. Int J Lab Hematol. 2021 Feb; 43(1):139-142.
    View in: PubMed
    Score: 0.145
  28. Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia. Psychiatr Q. 2019 03; 90(1):101-110.
    View in: PubMed
    Score: 0.131
  29. Monocytes from metabolic syndrome subjects exhibit a proinflammatory M1 phenotype. Metab Syndr Relat Disord. 2014 Sep; 12(7):362-6.
    View in: PubMed
    Score: 0.094
  30. Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats. Diab Vasc Dis Res. 2013 Nov; 10(6):550-3.
    View in: PubMed
    Score: 0.089
  31. Increased expression of Fc-? receptors on monocytes in patients with nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Sep; 98(9):E1510-5.
    View in: PubMed
    Score: 0.089
  32. Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects. Metab Syndr Relat Disord. 2013 Jun; 11(3):177-84.
    View in: PubMed
    Score: 0.086
  33. CRP induces hypertension in animal models: homo sapiens says no. Hypertens Res. 2011 Jul; 34(7):801-2.
    View in: PubMed
    Score: 0.076
  34. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol. 2011 Mar; 135(3):429-33.
    View in: PubMed
    Score: 0.075
  35. C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase. Clin Chem. 2010 Aug; 56(8):1345-8.
    View in: PubMed
    Score: 0.071
  36. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011 Feb; 60(2):256-9.
    View in: PubMed
    Score: 0.070
  37. Statin therapy for the metabolic syndrome: the evidence base. Metab Syndr Relat Disord. 2009 Oct; 7(5):393-6.
    View in: PubMed
    Score: 0.068
  38. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009 Sep; 206(1):61-8.
    View in: PubMed
    Score: 0.065
  39. Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): a real-time intravital microscopy study. Clin Hemorheol Microcirc. 2009; 42(4):285-95.
    View in: PubMed
    Score: 0.065
  40. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem. 2009 Feb; 55(2):361-4.
    View in: PubMed
    Score: 0.064
  41. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar 15; 44(6):1203-8.
    View in: PubMed
    Score: 0.060
  42. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr. 2007 Nov; 86(5):1392-8.
    View in: PubMed
    Score: 0.060
  43. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007 Dec; 43(6):780-91.
    View in: PubMed
    Score: 0.059
  44. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007 Nov; 56(11):2790-6.
    View in: PubMed
    Score: 0.059
  45. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res. 2007 Mar; 48(3):509-12.
    View in: PubMed
    Score: 0.056
  46. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov; 91(11):4489-96.
    View in: PubMed
    Score: 0.055
  47. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2469-75.
    View in: PubMed
    Score: 0.055
  48. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150.
    View in: PubMed
    Score: 0.054
  49. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol. 2006 Apr 04; 47(7):1379-81.
    View in: PubMed
    Score: 0.053
  50. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006 Mar; 55(3):774-9.
    View in: PubMed
    Score: 0.053
  51. Sources of CRP in atherosclerotic lesions. Am J Pathol. 2006 Mar; 168(3):1054-5; author reply 1055-6.
    View in: PubMed
    Score: 0.053
  52. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2216-21.
    View in: PubMed
    Score: 0.051
  53. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol. 2005 Apr; 166(4):1265-71.
    View in: PubMed
    Score: 0.050
  54. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. 2005 Jan; 14(1):33-7.
    View in: PubMed
    Score: 0.049
  55. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004 Jul; 44(1):6-11.
    View in: PubMed
    Score: 0.047
  56. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003 Oct 07; 108(14):1676-8.
    View in: PubMed
    Score: 0.045
  57. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003 Aug; 88(8):3773-6.
    View in: PubMed
    Score: 0.044
  58. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002 Sep 17; 106(12):1439-41.
    View in: PubMed
    Score: 0.042
  59. Increased eosinophils in adipose tissue of metabolic syndrome. J Diabetes Complications. 2019 08; 33(8):535-538.
    View in: PubMed
    Score: 0.033
  60. The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome. J Diabetes Complications. 2018 04; 32(4):379-383.
    View in: PubMed
    Score: 0.030
  61. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013 Apr; 44(2):194-204.
    View in: PubMed
    Score: 0.022
  62. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1782-8.
    View in: PubMed
    Score: 0.019
  63. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. Am J Cardiol. 2008 Aug 01; 102(3):321-5.
    View in: PubMed
    Score: 0.015
  64. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol. 2006 May; 26(5):995-1001.
    View in: PubMed
    Score: 0.013
  65. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med. 2004 May 15; 36(10):1329-41.
    View in: PubMed
    Score: 0.012
  66. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism. 2004 Feb; 53(2):236-40.
    View in: PubMed
    Score: 0.011
  67. Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. Lipids. 2003 Aug; 38(8):813-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.